Trv Gp Vi, LLC 13F holdings
Trv Gp Vi, LLC reported 4 positions with a total reported value of $232.3M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-10. Top holdings by reported value: SEPN SEPTERNA, INC. (60.7%), SPTX SEAPORT THEREAPEUTICS, INC. (19.3%), RAPP RAPPORT THERAPEUTICS, INC. (17.4%), TNGX TANGO THERAPEUTICS, INC. (2.6%). Against 2026-03-31 it opened 1 new position and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Trv Gp Vi, LLC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
4 largest of 4 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| SEPN SEPTERNA, INC. | 4,211,659 | $141.0M | 60.7% |
| SPTX SEAPORT THEREAPEUTICS, INC. | 2,061,222 | $44.8M | 19.3% |
| RAPP RAPPORT THERAPEUTICS, INC. | 969,218 | $40.4M | 17.4% |
| TNGX TANGO THERAPEUTICS, INC. | 194,174 | $6.1M | 2.6% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 1 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| SPTX SEAPORT THEREAPEUTICS, INC. | 2,061,222 | $44.8M | 19.3% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 0 in all · reported value as of 2026-03-31
No positions were sold out.
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
No position was increased.
Decreases
No position was decreased.
CIK 1990716 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
